Neuroprotection from Hypoxia, Ischemia, and Glucose Derangements

Introduction

• Because the brain has exceptionally high metabolic demands and relies almost entirely on aerobic glucose metabolism, it is vulnerable to hypoxic and ischemic insults. Perioperative cerebral injury ranges from subtle cognitive decline to disabling or fatal stroke, which can occur across surgical settings, with the highest risk in cardiac and major vascular procedures.
• As surgical patients age and accumulate comorbidities, the population at risk continues to grow. Although experimental work has identified promising neuroprotective pathways, pharmacologic strategies have shown inconsistent clinical benefit.
• Therefore, meticulous control of physiologic variables such as oxygenation, perfusion, ventilation, temperature, and glucose is the foundation of effective perioperative neuroprotection against hypoxic-ischemic insults and glycemic derangements.

Cerebral Physiology: Cerebral Metabolic Rate of Oxygen (CMRO₂) and Cerebral Blood Flow (CBF)

• The brain consumes approximately 20% of the body’s oxygen at rest. Most of this oxygen is used to generate adenosine triphosphate (ATP), which is required for specific functions.¹
• As much as 80% of brain oxygen consumption and ATP is used to support synaptic activity and action potentials. In contrast, the remainder is used for baseline cellular homeostasis, including membrane potential and organelle function.
• Under normal conditions, glucose is the primary substrate, although ketone bodies can partially substitute during periods of starvation.
• Cerebral metabolism, therefore, demands continuous delivery of oxygen and glucose, which is met by tightly regulated CBF.^1,2

CMRO₂

• Average whole brain CMRO₂ ≈ 3 mL O₂/100 g/min.
• Gray matter has substantially higher flow and metabolism than white matter.²

CBF

• Global CBF in healthy adults is ≈ 50 mL/100 g/min, distributed unevenly between gray matter (≈80 mL/100g/min) and white matter (≈25 mL/100 g/min).

Coupling of CMRO₂ and CBF

• Under physiologic conditions, CBF is tightly matched to metabolic demand through two mechanisms:^2,3
  • Neurovascular coupling: An increase in local/regional synaptic activity triggers vasodilation and increased flow via endothelial mediators (nitric oxide, prostanoids) and metabolic signals (lactate, adenosine), thereby supporting regional increases in glucose and oxygen delivery.
  • Autoregulation of CBF: In healthy adults, CBF is kept relatively stable across a range of cerebral perfusion pressures (CPP) through dynamic changes in cerebrovascular resistance.³ CPP is the difference between mean arterial pressure (MAP) and the intracranial pressure (ICP).
  • According to recent clinical data the lower limit of autoregulation (LLA) lies around 60 mmHg CPP, but there is substantial inter-individual variability even in healthy adults. This corresponds to a MAP of 70 mmHg, assuming normal ICP conditions.
  • Many anesthetized patients may drift below the LLA at MAP values previously considered acceptable, highlighting the risk of intraoperative hypotension. Several physiological factors and conditions (e.g., arterial CO₂ and chronic hypertension) influence autoregulation^3,4 (See: “Cerebral Autoregulation” summary for more details Link) (Figure 1.).

Hypoxic and Ischemic Insults

Hypoxia

Cerebral hypoxia occurs when oxygen delivery fails to meet cellular metabolic demands, due to impaired oxygenation, reduced oxygen-carrying capacity, low flow, or impaired utilization.

Classification of hypoxia:

• Hypoxemic hypoxia: reduced arterial oxygen tension (e.g., respiratory failure).
• Anemic hypoxia: severe anemia or hemodilution reducing oxygen content.
• Stagnant (circulatory) hypoxia: severe hypotension, low cardiac output, or circulatory arrest.
• Histotoxic hypoxia: impaired cellular utilization of oxygen (e.g., mitochondrial toxins).

Ischemia

Blood flow is insufficient to meet metabolic needs, regardless of arterial oxygen content.

• Global: cardiac arrest, profound hypotension/shock.
• Focal: thromboembolic occlusion, atherosclerosis, vasospasm, surgical compromise (e.g., temporary clip placement, carotid cross-clamping).

Ischemic Core versus Penumbra

Flow thresholds for functional failure versus tissue infarction delineate the ischemic core, penumbra, and vulnerable zones.^5-7

• Ischemic core: Severe flow reduction (≈ <10–12 mL•100 g^-1•min^-1) causes rapid ATP depletion and irreversible injury. Cellular integrity is lost.
• Ischemic penumbra: Moderately reduced flow (≈ 10–20 mL•100 g^-1•min^-1) leads to loss of electrical activity but partial preservation of energy production, maintaining cellular integrity. In the event of large vessel occlusion, flow is dependent on collaterals through the circle of Willis and through extracranial to intracranial connections (e.g., leptomeningeal collaterals). Tissue is potentially salvageable for a limited time if perfusion and metabolic environment are restored.
• Vulnerable zone: At CBF values 20-40 mL•100 g^-1•min^-1, neuronal viability is not threatened, but neuronal function may be slightly impacted depending on metabolic needs (Figure 2).

Mechanism of Neuronal Injury

• As oxygen tension falls, oxidative phosphorylation fails and ATP production declines, triggering a hypoxia-ischemic injury cascade. Because the brain has a minimal energy reserve and limited anaerobic capacity, even brief episodes of significant hypoxia/ischemia can cause measurable injury, especially in regions with higher metabolic demand.^5,7
• This cascade is influenced by homeostatic factors such as temperature, glucose level, and hemodynamics, which are therefore important targets for neuroprotective interventions (Figure 3).

Protection Against Hypoxic and Ischemic Insults

• Neuroprotection against hypoxia and ischemia focuses on preserving adequate oxygen and substrate delivery, avoiding secondary insults, and salvaging penumbral tissue.

Diagnostic and Monitoring Strategies

• Non-invasive monitoring: continuous blood pressure, pulse oximetry, capnography, electroencephalography, near-infrared spectroscopy (NIRS), transcranial Doppler (TCD), CT/MRI perfusion.
• Invasive monitoring: ICP, brain tissue oxygen, cerebral microdialysis

Personalized Hemodynamic Targets and Autoregulation-Guided Care

• “One-size-fits-all” MAP thresholds (e.g., ≥ 65–70 mm Hg) ignore the wide variability in individual autoregulatory limits.
• Continuous autoregulation monitoring using TCD, NIRS, and ICP has been used to derive individualized “optimal MAP” ranges, defined as the pressure range at which autoregulation is maintained for a given patient.^3,4,10 In a study using NIRS-derived indices during cardiopulmonary bypass, a wide variability in LLA was observed (LLA often near 65–70 mmHg MAP, with a broad range).¹⁰
• This supports autoregulation-oriented BP management, targeting a pressure range centered on each patient’s optimal value rather than a fixed population threshold. Although these approaches are promising, they are not yet standard of care in most perioperative environments.
• Practical implications:
  • When autoregulation monitoring is not available, avoidance of MAPs below population-based thresholds is crucial, especially in chronic hypertension or cerebrovascular disease.^3,4,10
  • Avoid excessive hypertension above the upper limit, which may promote edema or hemorrhagic transformation in ischemic tissue.⁸

Blood Pressure Management for Acute Ischemic Stroke Intervention

• In acute ischemic stroke, BP management must balance perfusion to penumbra against risk of hemorrhagic transformation and edema
• AHA/ASA guidelines recommend treating markedly elevated BP before IV thrombolysis (e.g., to <185/110 mmHg) and maintaining BP ≤180/105 mmHg during and after thrombolysis or mechanical thrombectomy. However, overly aggressive lowering of BP after reperfusion may worsen the outcome.⁸

Ventilation and Oxygenation Strategies

Oxygenation and ventilatory management aim to maintain adequate oxygenation of neurons and avoid deleterious CO₂-mediated changes in CBF: ^2-4,7 (Table 1)

• When autoregulation is compromised (e.g., stroke and TBI), CBF becomes highly pressure- and CO₂-dependent, and careful control of both MAP and PaCO₂ is crucial.

Temperature Management

• Fever reliably worsens ischemic injury and is associated with poorer neurologic outcomes (See: “Neuroprotection Through Hypothermia and Anesthetics” summary Link).

Glucose Derangements and Management

Glucose is the principal energy substrate for the adult brain. Even brief hypoglycemia and sustained hyperglycemia can trigger neuronal dysfunction and injury.⁹

Hypoglycemia

• Energy failure with loss of ion-gradient homeostasis
• Increased seizure risk
• Enhanced excitotoxicity during reperfusion or subsequent ischemic episodes
• Rebound hyperglycemia may further amplify neuronal damage.

Hyperglycemia

In acute brain injury and perioperative settings, hyperglycemia is associated with:

• Increased anaerobic glycolysis and lactate production → intracellular acidosis
• Oxidative stress and mitochondrial dysfunction
• Blood–brain barrier disruption, neuroinflammation, and cerebral edema
• Worse functional outcomes and higher mortality

Practical Glycemic Targets

• The intraoperative goal is to avoid hypoglycemia entirely and prevent prolonged or marked hyperglycemia.
• In most perioperative and intensive care unit settings, many guidelines support moderate glucose targets (e.g., 140–180 mg/dL).^8,9
• Vigilance is warranted in patients on insulin, sulfonylureas, and during long or high-risk procedures.